Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium.

MLA

El Zarif, Talal, et al. “Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, vol. 41, no. 21, July 2023, pp. 3712–23. EBSCOhost, https://doi.org/10.1200/JCO.22.02459.

APA

El Zarif, T., Nassar, A. H., Adib, E., Fitzgerald, B. G., Huang, J., Mouhieddine, T. H., Rubinstein, P. G., Nonato, T., McKay, R. R., Li, M., Mittra, A., Owen, D. H., Baiocchi, R. A., Lorentsen, M., Dittus, C., Dizman, N., Falohun, A., Abdel-Wahab, N., Diab, A., … Naqash, A. R. (2023). Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 41(21), 3712–3723. https://doi.org/10.1200/JCO.22.02459

Chicago

El Zarif, Talal, Amin H Nassar, Elio Adib, Bailey G Fitzgerald, Jiaming Huang, Tarek H Mouhieddine, Paul G Rubinstein, et al. 2023. “Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium.” Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 41 (21): 3712–23. doi:10.1200/JCO.22.02459.